Berlin, Germany

Markus Berger

This inventor holds 40 USPTO granted patents and 23 published patent applications, plus 6 CIPO patents and 19 EPO patents, primarily in MRI Contrast Agents. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Schering Pharma Ag, Astrazeneca Ab. Active years: 2005-2026.

USPTO Granted Patents = 40 

% Patents Active = 37.5

 

 

Average Co-Inventor Count = 7.6

ph-index = 5

Forward Citations = 106(Granted Patents)


Company Filing History:


Years Active: 2005-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Gadolinium Chelate Compounds
Magnetic Resonance Imaging
Anti-Inflammatory Agents
Ectoparasite-Controlling Agents
Pyrrolidine Derivatives
Indazole Derivatives
Tetrahydronaphthalene Derivatives
Quinoline Derivatives
Effector Conjugates
Chemical Compounds
40 patents (USPTO):Explore Patents

Title: Markus Berger: Innovator in Medical and Agricultural Solutions

Introduction

Markus Berger is a prolific inventor based in Berlin, Germany, known for his significant contributions to the fields of medicine and agriculture. With an impressive total of 35 patents to his name, Berger continues to push the boundaries of innovation focusing on critical health and environmental challenges.

Latest Patents

Among his latest innovations are groundbreaking patents that emphasize his expertise in medical imaging and pest control. His patent titled "High Relaxivity Gadolinium Chelate Compounds for Use in Magnetic Resonance Imaging" introduces a new class of high relaxivity extracellular gadolinium chelate complexes. This invention outlines methods for preparing these compounds and their application as MRI contrast agents, enhancing diagnostic accuracy in medical imaging.

Additionally, Berger developed a patent for a "Prolonged Ectoparasite-controlling Agent for Animals," which describes a compound utilized for the prolonged control of ectoparasites in animals. This patent includes a systemic application preparation and highlights applications in horticulture and agriculture, providing a novel way to protect crops from harmful organisms.

Career Highlights

Markus Berger has held significant roles at renowned companies such as Bayer Pharma Aktiengesellschaft and Bayer Schering Pharma AG. His work at these institutions has contributed to impactful developments in pharmaceutical research and agricultural innovations.

Collaborations

Throughout his career, Berger has collaborated with notable professionals like Hartmut Rehwinkel and Stefan Jaroch. These collaborations highlight the importance of teamwork and interdisciplinary approaches in fostering innovation in the fields of healthcare and agriculture.

Conclusion

Markus Berger exemplifies the spirit of innovation through his extensive patent portfolio and collaborative work. His contributions not only advance medical technology but also provide sustainable solutions for agricultural challenges. As an inventor, he continues to inspire new generations of researchers and innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…